[ Price : $8.95]
During recent drug user fee negotiations on reauthorizing the PDUFA program, FDA officials and pharmaceutical industry representat...[ Price : $8.95]
FDA approves a new subcutaneous formulation of Johnson & Johnsons lung cancer drug amivantamab, allowing the therapy to be adminis...[ Price : $8.95]
Regulators place a clinical hold on a pivotal lung cancer trial of ifinatamab deruxtecan after reports of treatment-related deaths...[ Price : $8.95]
House Energy and Commerce Committee Republicans blocked an effort by Democrats to compel HHS secretary Robert F. Kennedy Jr. to te...[ Price : $8.95]
Sen. Ron Johnson (R-WI) demands that FDA turn over records related to an internal review that linked Covid-19 vaccinations to the ...[ Price : $8.95]
FDA publishes a guidance clarifying how it evaluates real-world data to determine if they are sufficient to provide real-world evi...[ Price : $8.95]
FDA selects investigational cholesterol and cancer drugs from Merck for expedited regulatory reviews under its Commissioner's Nati...[ Price : $8.95]
FDA issues a Warning Letter to Catalents Bloomington, IN, drug manufacturing plant, citing significant manufacturing violations af...